Welcome to LookChem.com Sign In|Join Free

CAS

  • or

68-96-2

Post Buying Request

68-96-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

68-96-2 Usage

Chemical Properties

White Solid

Originator

Prodox,Upjohn

Uses

Different sources of media describe the Uses of 68-96-2 differently. You can refer to the following data:
1. Progesteron. It was isolated from adrenal glands.
2. anticoagulant
3. 17α-Hydroxy Progesterone is a metabolite of Progesterone. It was isolated from adrenal glands.

Definition

ChEBI: A 17alpha-hydroxy steroid that is the 17alpha-hydroxy derivative of progesterone.

Indications

Hydroxyprogesterone has been used prophylactically for the 12th to 37th week of pregnancy, particularly in women who are in the high-risk category for premature delivery (e.g., those with a history of premature delivery or spontaneous abortion). A concern relating to teratogenic potential has limited its use. Hydroxyprogesterone as a tocolytic agent requires further evaluation before its routine prophylactic administration can be recommended.

Manufacturing Process

A suspension of 90.0 g of δ5-pregnen-3β,17α-diol-20-one in 2300 ml of 85% formic acid was shaken for 2 h at a temperature of 70C. During this time the compound partially dissolved and at the same time a new crystalline substance appeared in the solution. After cooling, the precipitate was filtered, thus giving 80.0 g of the 3-formate of δ5-pregnen-3β,17α-diol-20-one having a melting point of 204°-207°C. 5.0 g of the 3-formate of δ5-pregnen-3β,17α-diol-20-one suspended in 120 ml of acetic anhydride was treated with 1.5 g of p-toluenesulfonic acid and the mixture was stirred for 9 h at room temperature. It was poured into water and after 2 h standing, the precipitate was filtered and washed to neutral, thus yielding the 3-formate 17-acetate of δ5-pregnen-3β,17α-diol-20-one in a yield of over 90%. 1.0 g of 3-formate 17-acetate of δ5-pregnen-3β,17α-diol-20-one was dissolved in 30 ml of xylene and 10 ml of cyclohexanone and 4 ml of the solution were distilled in order to remove traces of moisture. 1.0 g of aluminum isopropylate was added to the hot solution and the mixture was refluxed for 45 min. After cooling to 90°C, water was added and the organic solvents were removed by steam distiliation. Salt was added to the aqueous suspension and the residue was filtered, dried and extracted with hot acetone. The acetone solution was evaporated to dryness and the residue was crystallized from chloroformmethanol, thus giving 610.0 mg of the 17-acetate of δ4-pregnen-17α-ol-3,20- dione (17-acetoxy-progesterone) with a melting point of 239°-240°C. Saponification of this compound with 1% methanolic potassium hydroxide yielded 80% of δ4-pregnen-17α-ol-3,20-dione.

Therapeutic Function

Progestin

Biological Activity

17-hydroxyprogesterone, an endogenous progestogen and chemical intermediate in the biosynthesis of other steroid hormones, is also the parent compound of various progestins derivatives.

Synthesis

Hydroxyprogesterone, 17α-hydroxypregn-4-en-3,20-dione (28.3.6), is synthesized from dehydropregnenolon (28.3.2). Dehydropregnenolon itself is made by successive decomposition and oxidation of the side spiroketal group of diosgenin—the aglycone of one of the saponins of plant origin isolated from Discorea. The double bond at C16–C17 or dehydropregnenolon is oxidized by hydrogen peroxide in the presence of a base to give an epoxide (28.3.3). Interaction of the resulting epoxide with hydrogen bromide in acetic acid forms a bromohydrin (28.3.4). The hydroxyl group of C3 of the steroid system is formylated by formic acid, and reduction by hydrogen over a palladium catalyst removes the bromine atom at C16, forming the product (28.3.5). The hydroxyl group at C17 of this product is acylated by acetic acid anhydride and then the formyl group at C3 is oxidized by aluminum isopropylate in the presence of cyclohexanone, during which simultaneous isomerization takes place at the double bond, isomerizes from C5–C6 to position C4–C5, forming the desired hydroprogesterone ester, in the given case an acetate (28.3.6), in which form it is used in medical practice. Other alternative ways of synthesis have been proposed.

in vitro

17-hydroxyprogesterone was found to be an agonist of the progesterone receptor (pr), which was similarly to progesterone. in addition, 17-hydroxyprogesterone was also an antagonist of the mineralocorticoid receptor (mr) as well as a partial agonist of the glucocorticoid receptor (gr), with very low potency (ec50>100-fold less relative to cortisol), which was also similarly to progesterone [1].

in vivo

findings from a previous rat in vivo study demonstrated that even if modest, lowering blood pressure with 17-hydroxyprogesterone could be a viable treatment selection for blocking inflammation and uterine artery vasoconstriction, whereas improving litter size [2].

references

[1] barbara j. attardi, et al. comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate (17-ohpc), and related progestins. am j obstet gynecol. 2007 dec; 197(6): 599.e1–599.e7.[2] lorena m. amaral, et al. 17- hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the rupp rat model. hypertension. 2015 jan; 65(1): 225–231.[3] ryckman kk,cook de,berberich sl,shchelochkov oa,berends sk,busch t,dagle jm,murray jc. replication of clinical associations with 17-hydroxyprogesterone in preterm newborns. j pediatr endocrinol metab. 2012;25(3-4):301-5.

Check Digit Verification of cas no

The CAS Registry Mumber 68-96-2 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 6 and 8 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 68-96:
(4*6)+(3*8)+(2*9)+(1*6)=72
72 % 10 = 2
So 68-96-2 is a valid CAS Registry Number.
InChI:InChI=1/C21H30O3/c1-13(22)21(24)11-8-18-16-5-4-14-12-15(23)6-9-19(14,2)17(16)7-10-20(18,21)3/h12,16-18,24H,4-11H2,1-3H3

68-96-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (H1250)  17α-Hydroxyprogesterone  >98.0%(HPLC)

  • 68-96-2

  • 5g

  • 190.00CNY

  • Detail
  • TCI America

  • (H1250)  17α-Hydroxyprogesterone  >98.0%(HPLC)

  • 68-96-2

  • 25g

  • 680.00CNY

  • Detail

68-96-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 17α-hydroxyprogesterone

1.2 Other means of identification

Product number -
Other names Pregn-4-ene-3,20-dione, 17-hydroxy-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:68-96-2 SDS

68-96-2Synthetic route

17α-hydroxy-21-chloro-4-pregnene-3,20-dione
20380-16-9

17α-hydroxy-21-chloro-4-pregnene-3,20-dione

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With acetic acid; zinc100%
With titanium(III) sulphate; sulfuric acid; ammonia In methanol for 10h;83%
cyclic-3-(1,2-ethanediylmercapto)-17α-hydroxypregn-4-en-20-one
1202062-99-4

cyclic-3-(1,2-ethanediylmercapto)-17α-hydroxypregn-4-en-20-one

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With water; calcium carbonate; methyl iodide In ethanol for 20h; Heating; Inert atmosphere;100%
21-Iodo-17α-hydroxypregn-4-en-3,20-dione
4470-79-5

21-Iodo-17α-hydroxypregn-4-en-3,20-dione

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With mercaptoacetic acid In formamide for 0.25h; Ambient temperature;97.7%
C23H34NO3(1-)*Zn(2+)*Br(1-)

C23H34NO3(1-)*Zn(2+)*Br(1-)

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 40℃; for 4h; pH=1.5 - 2; Temperature; Reagent/catalyst;97.4%
17β-Ethynyl-17α-hydroxyandrost-4-en-3-one
83509-38-0

17β-Ethynyl-17α-hydroxyandrost-4-en-3-one

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With sulfuric acid; mercury(II) sulfate In water; acetone at 50 - 55℃; for 6h; Temperature;86%
C22H31NO3

C22H31NO3

dimethyl zinc(II)
544-97-8

dimethyl zinc(II)

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
Stage #1: C22H31NO3; dimethyl zinc(II) With lithium chloride In toluene at 60 - 65℃;
Stage #2: With hydrogenchloride In water at 55 - 60℃; Solvent; Reagent/catalyst;
85.2%
16-dehydroprogesterone
1096-38-4

16-dehydroprogesterone

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
Stage #1: 16-dehydroprogesterone With phenylsilane; oxygen; isopropyl alcohol; Mn(dpm)3 In 1,2-dichloro-ethane at 0 - 25℃;
Stage #2: With triethyl phosphite In 1,2-dichloro-ethane
85%
Multi-step reaction with 2 steps
1: 79 percent / RhCl(PPh3)3
2: mCPBA / RhCl(PPh3)3 / CH2Cl2
View Scheme
16-dehydroprogesterone
1096-38-4

16-dehydroprogesterone

Mn(dpm)3

Mn(dpm)3

1,2-dichloro-ethane
107-06-2

1,2-dichloro-ethane

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
In isopropyl alcohol85%
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With water; sodium hydroxide In methanol for 1h; Reflux;83.3%
With potassium hydroxide
21-Iodo-17α-hydroxypregn-4-en-3,20-dione
4470-79-5

21-Iodo-17α-hydroxypregn-4-en-3,20-dione

mercaptoacetic acid
68-11-1

mercaptoacetic acid

A

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

B

(17α-Hydroxy-4-pregnene-3,20-dion-21-yl-21-thio)acetic acid
114967-85-0

(17α-Hydroxy-4-pregnene-3,20-dion-21-yl-21-thio)acetic acid

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 80℃;A 71.8%
B 24.6%
(8S,9S,10R,13S,14S,Z)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
51154-62-2

(8S,9S,10R,13S,14S,Z)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one

A

Androstenedione
63-05-8

Androstenedione

B

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

C

17alpha,20beta-Dihydroxypregn-4-en-3-one
1662-06-2

17alpha,20beta-Dihydroxypregn-4-en-3-one

Conditions
ConditionsYield
With ruthenium trichloride; Oxone; sodium hydrogencarbonate In water; ethyl acetate; acetonitrile at -20 - 30℃;A 10%
B 70%
C 20%
C23H34O
1356399-45-5

C23H34O

A

Androstenedione
63-05-8

Androstenedione

B

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

C

17ξ,20ξ-epoxy-pregna-Δ4-dien-3-one

17ξ,20ξ-epoxy-pregna-Δ4-dien-3-one

Conditions
ConditionsYield
With ruthenium trichloride; tetra(n-butyl)ammonium hydrogensulfate In dichloromethane; water at 20℃;A 10%
B 70%
C 20%
pregn-4-ene-3ξ,17α,20ξ-triol

pregn-4-ene-3ξ,17α,20ξ-triol

A

Androstenedione
63-05-8

Androstenedione

B

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With tetrapropylammonium perruthennate; 4 A molecular sieve; 4-methylmorpholine N-oxide In dichloromethane; acetonitrile for 0.75h;A 60%
B 20%
Progesterone
57-83-0

Progesterone

A

Androstenedione
63-05-8

Androstenedione

B

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

C

6-oxoprogesterone
2243-08-5

6-oxoprogesterone

D

A-nor-5β-pregnanedione-(3.20)
100979-81-5

A-nor-5β-pregnanedione-(3.20)

E

4α-formyl-A-nor-pregnene-3,20-dione
135574-05-9

4α-formyl-A-nor-pregnene-3,20-dione

F

pregn-4-ene-3,12,20-trione
55203-20-8

pregn-4-ene-3,12,20-trione

Conditions
ConditionsYield
With 2-Picolinic acid; dihydrogen peroxide; iron(III) chloride In pyridine; acetic acid for 18h; Product distribution; Mechanism; Ambient temperature;A 4.3%
B 5.7%
C 10.7%
D 5%
E 19.3%
F 17.1%
Progesterone
57-83-0

Progesterone

A

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

B

6-oxoprogesterone
2243-08-5

6-oxoprogesterone

C

4α-formyl-A-nor-pregnene-3,20-dione
135574-05-9

4α-formyl-A-nor-pregnene-3,20-dione

D

pregn-4-ene-3,12,20-trione
55203-20-8

pregn-4-ene-3,12,20-trione

Conditions
ConditionsYield
With 2-Picolinic acid; dihydrogen peroxide; iron(III) chloride In pyridine; acetic acid for 18h; Ambient temperature; Further byproducts given;A 5.7%
B 10.7%
C 19.3%
D 17.1%
Pregnenolone
145-13-1

Pregnenolone

A

testosterone
58-22-0

testosterone

B

Androstenedione
63-05-8

Androstenedione

C

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With glucose-6-phosphate dehydrogenase; propylene glycol; D-glucose; cortical tissue of mare adrenals at 37℃; for 2h; Product distribution; <3H>labelled;A 0.15%
B 5.1%
C n/a
1,4-dioxane
123-91-1

1,4-dioxane

diethyl ether
60-29-7

diethyl ether

17α-hydroxy-3-oxo-androst-4-ene-17β-carbaldehyde

17α-hydroxy-3-oxo-androst-4-ene-17β-carbaldehyde

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
und Chromatographieren des Reaktionsprodukts an Aluminiumoxyd;
pyridine
110-86-1

pyridine

4ξ-bromo-17-hydroxy-5β-pregnane-3,20-dione

4ξ-bromo-17-hydroxy-5β-pregnane-3,20-dione

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
at 110 - 130℃;
Pregnenolone
145-13-1

Pregnenolone

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With flavobacterium 'androstendionicum'
5α-Chloro-3β,17α-dihydroxypregnan-20-one
83914-31-2

5α-Chloro-3β,17α-dihydroxypregnan-20-one

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With pyridine; chromium(VI) oxide anschliessend mit wss.NaOH;
5,6β-dichloro-3β,17-dihydroxy-5α-pregnan-20-one
28439-56-7

5,6β-dichloro-3β,17-dihydroxy-5α-pregnan-20-one

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With chromium(VI) oxide; chromium dichloride; sulfuric acid beim aufeinanderflogenden Behandeln;
17-hydroxy-16β-iodo-pregn-4-ene-3,20-dione
100733-64-0

17-hydroxy-16β-iodo-pregn-4-ene-3,20-dione

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With nickel
17-hydroxy-2ξ-iodo-pregn-4-ene-3,20-dione
418768-63-5

17-hydroxy-2ξ-iodo-pregn-4-ene-3,20-dione

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With chromium dichloride
3β,20βF-diacetoxy-pregnen-(5)-ol-(17)
101978-51-2

3β,20βF-diacetoxy-pregnen-(5)-ol-(17)

cyclohexanone
108-94-1

cyclohexanone

aluminum isopropoxide
555-31-7

aluminum isopropoxide

toluene
108-88-3

toluene

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

20,20-ethanediyldioxy-pregn-5-ene-3β,17-diol
13714-60-8

20,20-ethanediyldioxy-pregn-5-ene-3β,17-diol

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With cyclohexanone; aluminum isopropoxide anschliessend Behandeln mitwss.-methanol.H2SO4;
methanol
67-56-1

methanol

1-methyl-4-nitrosobenzene
623-11-0

1-methyl-4-nitrosobenzene

20ξ-acetylamino-17,20ξ-epoxy-pregn-4-en-3-one
102813-01-4

20ξ-acetylamino-17,20ξ-epoxy-pregn-4-en-3-one

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

20ξ-acetylamino-17,20ξ-epoxy-pregn-4-en-3-one
102813-01-4

20ξ-acetylamino-17,20ξ-epoxy-pregn-4-en-3-one

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Conditions
ConditionsYield
With sodium hydroxide
Progesterone
57-83-0

Progesterone

A

HYDROCORTISONE
50-23-7

HYDROCORTISONE

B

17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

C

21-Hydroxyprogesterone
64-85-7

21-Hydroxyprogesterone

D

Corticosterone
50-22-6

Corticosterone

E

Cortexolone
152-58-9

Cortexolone

Conditions
ConditionsYield
With glucose-6-phosphate dehydrogenase; phosphate buffer; air; α-D-glucose 6-phosphate; midterm female fetal human adrenal tissue; NADP; magnesium chloride at 37℃; for 2h; Product distribution; <3H>labeled;A 36.3 % Chromat.
B n/a
C n/a
D 4.7 % Chromat.
E n/a
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

21-Iodo-17α-hydroxypregn-4-en-3,20-dione
4470-79-5

21-Iodo-17α-hydroxypregn-4-en-3,20-dione

Conditions
ConditionsYield
With iodine; calcium chloride; calcium oxide In methanol; dichloromethane; water 1.) 10-12 deg C above room temp., 15 min., 2.) room temp., 30 min.;99.3%
With 2,2'-azobis(isobutyronitrile); iodine; calcium oxide In tetrahydrofuran; methanol at 20℃; for 5h; Inert atmosphere;90%
With tetrahydrofuran; iodine
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

Androstenedione
63-05-8

Androstenedione

Conditions
ConditionsYield
In water; acetonitrile at 20℃; Electrochemical reaction;99%
With tetrapropylammonium perruthennate; 4 A molecular sieve; 4-methylmorpholine N-oxide In dichloromethane; acetonitrile for 0.75h;95%
With chromium(VI) oxide; acetic acid
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

C25H37BrNO2(1+)*Cl(1-)

C25H37BrNO2(1+)*Cl(1-)

Conditions
ConditionsYield
Stage #1: 17-hydroxyprogesterone With pyrrolidine In methanol at 0℃; Reflux; Inert atmosphere;
Stage #2: With hydrogenchloride; bromine In ethanol; water at 20℃; for 4h;
98%
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

acetic anhydride
108-24-7

acetic anhydride

cortexolone 21-acetate
640-87-9

cortexolone 21-acetate

Conditions
ConditionsYield
Stage #1: 17-hydroxyprogesterone With calcium chloride; calcium oxide In methanol; chloroform for 2h;
Stage #2: acetic anhydride With potassium carbonate; acetic acid In methanol; chloroform; N,N-dimethyl-formamide at 100℃; for 1h;
98%
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

potassium acetate
127-08-2

potassium acetate

cortexolone 21-acetate
640-87-9

cortexolone 21-acetate

Conditions
ConditionsYield
Stage #1: 17-hydroxyprogesterone With pyrrolidine In ethanol at 0 - 50℃;
Stage #2: potassium acetate With acetic acid; potassium iodide In ethanol; acetone at 20 - 60℃;
98%
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

m-Iodbenzoesaeureanhydrid
75863-28-4

m-Iodbenzoesaeureanhydrid

17α-(m-iodobenzoyloxy)progesterone
74176-91-3

17α-(m-iodobenzoyloxy)progesterone

Conditions
ConditionsYield
With dmap In toluene at 50℃; for 18h;95%
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

(8R,9S,10S,13S,14S,17R)-17-Acetyl-2,17-dihydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-cyclopenta[a]phenanthren-3-one
110673-94-4

(8R,9S,10S,13S,14S,17R)-17-Acetyl-2,17-dihydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-cyclopenta[a]phenanthren-3-one

Conditions
ConditionsYield
With 18-crown-6 ether; potassium tert-butylate; oxygen In toluene at -25℃; for 2.5h;95%
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

A

(1R,8S,9S,10R,13S,14S,17R)-17-Acetyl-1,17-dihydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-2-oxa-cyclopenta[a]phenanthren-3-one
138430-10-1

(1R,8S,9S,10R,13S,14S,17R)-17-Acetyl-1,17-dihydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-2-oxa-cyclopenta[a]phenanthren-3-one

B

(1S,8S,9S,10R,13S,14S,17R)-17-Acetyl-1,17-dihydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-2-oxa-cyclopenta[a]phenanthren-3-one
110673-96-6

(1S,8S,9S,10R,13S,14S,17R)-17-Acetyl-1,17-dihydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-2-oxa-cyclopenta[a]phenanthren-3-one

Conditions
ConditionsYield
With crown ether; potassium tert-butylate; oxygen In toluene 1.) -25 deg C, 1.5-4 h, 2.) -20 deg C, 7 d; Title compound not separated from byproducts;A n/a
B 95%
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

acetic anhydride
108-24-7

acetic anhydride

pregna-3,5-dien-20-one, 3,17-dihydroxy-, diacetate
4954-07-8

pregna-3,5-dien-20-one, 3,17-dihydroxy-, diacetate

Conditions
ConditionsYield
With perchloric acid In ethyl acetate for 0.1h;92%
With perchloric acid In ethyl acetate at 20℃; for 0.5h;39%
With toluene-4-sulfonic acid
With sodium hydrogen sulfate In tetrahydrofuran at 50℃; for 5h; Reagent/catalyst; Temperature; Solvent;
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

17aβ-hydroxy-17aα-methyl-D-homoandrost-4-en-3,17-dione
14510-23-7

17aβ-hydroxy-17aα-methyl-D-homoandrost-4-en-3,17-dione

Conditions
ConditionsYield
iodine; zinc In benzene Heating;90%
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

1,4,6-triene-3,20-dione-17α-hydroxyprogesterone
66212-25-7

1,4,6-triene-3,20-dione-17α-hydroxyprogesterone

Conditions
ConditionsYield
Stage #1: 17-hydroxyprogesterone With pyridinium p-toluenesulfonate; orthoformic acid triethyl ester In ethanol at 39℃; for 6.5h;
Stage #2: With 2,3-dicyano-5,6-dichloro-p-benzoquinone In toluene at 87 - 90℃; for 3.5h; Temperature; Inert atmosphere;
82.7%
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

5β-17α-hydroxy-preganene-3,20-dione
570-58-1

5β-17α-hydroxy-preganene-3,20-dione

Conditions
ConditionsYield
With pyridine; palladium 10% on activated carbon; hydrogen In 1,4-dioxane; ethanol at 30℃; for 17h;77%
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

17α-hydroxy-4,5-epoxypregnan-3,20-dione

17α-hydroxy-4,5-epoxypregnan-3,20-dione

Conditions
ConditionsYield
With dihydrogen peroxide; sodium hydroxide In methanol; dichloromethane; water at 20℃; for 24h;73%
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

A

17alpha,20beta-Dihydroxypregn-4-en-3-one
1662-06-2

17alpha,20beta-Dihydroxypregn-4-en-3-one

B

pregn-4-en-3β,17α,20β-triol

pregn-4-en-3β,17α,20β-triol

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol at 0 - 5℃; for 1.5h;A 28%
B 70%
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

17α-hydroxypregna-3,5-dien-20-one
1096-63-5

17α-hydroxypregna-3,5-dien-20-one

Conditions
ConditionsYield
Stage #1: 17-hydroxyprogesterone With C19H26ClIrN3O(1+)*Cl(1-) In water; acetonitrile at 80℃; for 0.166667h; Green chemistry;
Stage #2: With formic acid In water; acetonitrile at 80℃; for 8h; Green chemistry; regioselective reaction;
70%
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

pyruvoyl chloride
5704-66-5

pyruvoyl chloride

(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1Hcyclopenta[a]phenanthren-17-yl methyl oxalate

(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1Hcyclopenta[a]phenanthren-17-yl methyl oxalate

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 0 - 20℃; Inert atmosphere;70%
17-hydroxyprogesterone
68-96-2

17-hydroxyprogesterone

A

4α,5α-epoxy-17α-hydroxy-A-homo-4-oxapregnan-3,20-dione

4α,5α-epoxy-17α-hydroxy-A-homo-4-oxapregnan-3,20-dione

B

4β,5β-epoxy-17α-hydroxy-A-homo-4-oxapregnan-3,20-dione

4β,5β-epoxy-17α-hydroxy-A-homo-4-oxapregnan-3,20-dione

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 0℃; for 24h;A 11%
B 66%

68-96-2Relevant articles and documents

Evaluation of the fluorescent probes Nile Red and 25-NBD-cholesterol as substrates for steroid-converting oxidoreductases using pure enzymes and microorganisms

Faletrov, Yaroslav V.,Frolova, Nina S.,Hlushko, Hanna V.,Rudaya, Elena V.,Edimecheva, Irina P.,Mauersberger, Stephan,Shkumatov, Vladimir M.

, p. 3109 - 3119 (2013)

The fluorescent probes Nile Red (nonsteroidal dye) and 25-{N-[(7-nitrobenz- 2-oxa-1,3-diazol-4-yl)-methyl]amino}-27-norcholesterol (25-NBD-cholesterol) (a cholesterol analog) were evaluated as novel substrates for steroid-converting oxidoreductases. Docking simulations with autodock showed that Nile Red fits well into the substrate-binding site of cytochrome P450 17α-hydroxylase/ 17,20-lyase (CYP17A1) (binding energy value of -8.3 kcal·mol -1). Recombinant Saccharomyces cerevisiae and Yarrowia lipolytica, both expressing CYP17A1, were found to catalyze the conversion of Nile Red into two N-dealkylated derivatives. The conversion by the yeasts was shown to increase in the cases of coexpression of electron-donating partners of CYP17A1. The highest specific activity value (1.30 ± 0.02 min-1) was achieved for the strain Y. lipolytica DC5, expressing CYP17A1 and the yeast's NADPH-cytochrome P450 reductase. The dye was also metabolized by pure CYP17A1 into the N-dealkylated derivatives, and gave a type I difference spectrum when titrated into low-spin CYP17A1. Analogously, docking simulations demonstrated that 25-NBD-cholesterol binds into the active site of the microbial cholesterol oxidase (CHOX) from Brevibacterium sterolicum (binding energy value of -5.6 kcal·mol-1). The steroid was found to be converted into its 4-en-3-one derivative by CHOX (Km and kcat values were estimated to be 58.1 ± 5.9 μm and 0.66 ± 0.14 s-1, respectively). The 4-en-3-one derivative was also detected as the product of 25-NBD-cholesterol oxidation with both pure microbial cholesterol dehydrogenase (CHDH) and a pathogenic bacterium, Pseudomonas aeruginosa, possessing CHOXs and CHDHs. These results provide novel opportunities for investigation of the structure-function relationships of the aforementioned oxidoreductases, which catalyze essential steps of steroid bioconversion in mammals (CYP17A1) and bacteria (CHOX and CHDH), with fluorescence-based techniques. Docking simulations show that fluorescent substances Nile Red and 25-NBD-cholesterol fit well the substrate-binding sites of CYP17A1 and the cholesterol oxidase (CHOX), respectively. Recombinant yeasts, expressing CYP17A1, as well as pure CYP17A1 catalyze the Nile Red conversion into N-dealkylated derivatives. 25-NBD-cholesterol is converted into its 4-en-3-one derivative by the CHOX and cholesterol dehydrogenase as well as by bacteria Pseudomonas aeruginosa.

Transformation of progesterone to 17alpha-hydroxyprogesterone by Trichoderma viride Pers. ex Fries.

MCALEER,DULANEY

, p. 111 - 112 (1956)

-

Modified bile acids and androstanes—Novel promising inhibitors of human cytochrome P450 17A1

Dzichenka, Yaraslau,Shapira, Michail,Yantsevich, Aliaksei,Cherkesova, Tatsiana,Grbovi?, Ljubica,Savi?, Marina,Usanov, Sergey,Jovanovi?-?anta, Suzana

, (2020/11/17)

Cytochromes P450 are key enzymes for steroid hormone biosynthesis in human body. They are considered as targets for the screening of novel high efficient drugs. The results of screening of bile acids and androstane derivatives toward human recombinant steroid 17α-hydroxylase/17,20-lyase (CYP17A1) are presented in this paper. A group of steroids, binding with micromolar or submicromolar affinity (in a range from 9 μM – less than 0.1 μM), was identified. Results presented here showed that these steroidal compounds are able to decrease rate of hydroxylation of essential CYP17A1 substrate – progesterone, while some compounds completely inhibited enzyme activity. Structure-activity relationship (SAR) analysis based on in vitro and in silico studies showed that high affinity of the enzyme to bile acids derivatives is correlated with side chain hydrophobicity and presence of hydroxyl or keto group at C3 position. From the other side, bile acid-derived compounds with more polar side chain or substituents at C7 and C12 positions possess higher Kd values. Among androstane-derived steroids couple of Δ5-steroids with hydroxyl group at C3 position, as well as 16,17-secosteroids, were found to be high affinity ligands of this enzyme. The data obtained could be useful for the design of novel highly efficient inhibitors of CYP17A1, since the bile acids-derived compounds are for first time recognized as effective CYP17A1 inhibitors.

A 17a - hydroxy progesterone preparation method

-

Paragraph 0017; 0018; 0019; 0020; 0021; 0022; 0023; 0024, (2017/08/25)

The invention relates to a method for preparing 17alpha-hydroxyprogesterone. The17alpha-hydroxyprogesterone is prepared by taking 17beta- cyano-5-androstene-17-ol-3,3-diethylene ketal (referred as an intermediate II) as a raw material and dimethylzinc or methylzinc chloride as a reagent; the content of the 17alpha-hydroxyprogesterone by HPLC is above 99.5% and the weight yield is 83-87%. The method comprises the following steps of dissolving the intermediate II in an organic solvent, adding lithium chloride as a catalyst, stirring, raising the temperature to 40-80 DEG C, dropwise adding a toluene solution of dimethylzinc or methylzinc chloride of which the concentration is 2M, and continuing to complete the reaction; and then adding an ammonium chloride solution of which the concentration is 25% to destruct an organic zinc reagent, separating the aqueous layer out and extracting, merging the organic layer and the extract and concentrating the solvent to near dryness, and then adding lower alcohol, stirring, raising the temperature to 40-60 DEG C, adding the acid of which the concentration is 2M, hydrolyzing, adjusting the pH value with a weak base after the reaction is completed, evaporating 90% of the solvent out, adding tap water, cooling and crystallizing to obtain a crude 17alpha-hydroxyprogesterone product; and then carrying out reflux decolorizing on the crude product with activated carbon by virtue of alcohol, and refining to obtain the commercial grade 17alpha-hydroxyprogesterone. The 17alpha-hydroxyprogesterone produced by the method disclosed by the invention has the advantages of good purity and high yield and is economic and environment-friendly, and the solvent can be recycled.

A high yield of 17 α - hydroxy progesterone of simple preparation method

-

Paragraph 0031; 0034; 0035; 0036; 0037; 0038; 0039; 0040, (2017/11/18)

The invention relates to a high-yield simple preparation method of 17alpha-hydroxy progesterone. With 4-androstenedione as an initial raw material, the method comprises the following steps: performing a cyanogen alcoholization addition reaction between the 17-site carbonyl of 4-androstenedione and acetone hydrogen alcohol to obtain 17-alpha hydroxyl-17-beta cyanoandrostane-4-ene-3-one; performing a ketal protection reaction of the C3-site carbonyl to obtain a ketal product; and performing a direct methylation reaction between the ketal product and zinc chloride methane, and hydrolyzing to obtain 17alpha-hydroxy progesterone. The method provided by the invention has the advantages of short process, high yield, high product purity, mild reaction conditions, low cost and low energy consumption and is particularly suitable for industrial production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 68-96-2